| Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in … RR Bahadoer, EA Dijkstra, B van Etten, CAM Marijnen, H Putter, ... The Lancet Oncology 22 (1), 29-42, 2021 | 952 | 2021 |
| Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study SR Kristjansson, A Nesbakken, MS Jordhøy, E Skovlund, RA Audisio, ... Critical reviews in oncology/hematology 76 (3), 208-217, 2010 | 489 | 2010 |
| Outcome and late functional results after anastomotic leakage following mesorectal excision for rectal cancer A Nesbakken, K Nygaard, OC Lunde Journal of British Surgery 88 (3), 400-404, 2001 | 461 | 2001 |
| Deep learning for prediction of colorectal cancer outcome: a discovery and validation study OJ Skrede, S De Raedt, A Kleppe, TS Hveem, K Liestøl, J Maddison, ... The Lancet 395 (10221), 350-360, 2020 | 429 | 2020 |
| Bladder and sexual dysfunction after mesorectal excision for rectal cancer A Nesbakken, K Nygaard, T Bull‐Njaa, E Carlsen, LM Eri British Journal of Surgery 87 (2), 206-210, 2000 | 415 | 2000 |
| Portrait of the PI3K/AKT pathway in colorectal cancer SA Danielsen, PW Eide, A Nesbakken, T Guren, E Leithe, RA Lothe Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1855 (1), 104-121, 2015 | 366 | 2015 |
| Short term outcome after emergency and elective surgery for colon cancer OH Sjo, S Larsen, OC Lunde, A Nesbakken Colorectal Disease 11 (7), 733-739, 2009 | 291 | 2009 |
| Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ... The lancet Gastroenterology & hepatology 1 (3), 207-216, 2016 | 280 | 2016 |
| Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer MG Guren, MT Eriksen, JN Wiig, E Carlsen, A Nesbakken, HK Sigurdsson, ... European Journal of Surgical Oncology (EJSO) 31 (7), 735-742, 2005 | 268 | 2005 |
| ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis TH Ågesen, A Sveen, MA Merok, GE Lind, A Nesbakken, RI Skotheim, ... Gut 61 (11), 1560-1567, 2012 | 264 | 2012 |
| The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery: proceedings of a consensus conference K Søndenaa, P Quirke, W Hohenberger, K Sugihara, H Kobayashi, ... International journal of colorectal disease 29, 419-428, 2014 | 258 | 2014 |
| Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ... Annals of Oncology 28 (5), 1023-1031, 2017 | 226 | 2017 |
| Colorectal cancer consensus molecular subtypes translated to preclinical models uncover potentially targetable cancer cell dependencies A Sveen, J Bruun, PW Eide, IA Eilertsen, L Ramirez, A Murumägi, ... Clinical Cancer Research 24 (4), 794-806, 2018 | 223 | 2018 |
| Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series MA Merok, T Ahlquist, EC Røyrvik, KF Tufteland, M Hektoen, OH Sjo, ... Annals of Oncology 24 (5), 1274-1282, 2013 | 212 | 2013 |
| DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset M Berg, SA Danielsen, T Ahlquist, MA Merok, TH Ågesen, MH Vatn, ... PloS one 5 (11), e13978, 2010 | 196 | 2010 |
| Frailty is an independent predictor of survival in older patients with colorectal cancer N Ommundsen, TB Wyller, A Nesbakken, MS Jordhøy, A Bakka, ... The oncologist 19 (12), 1268-1275, 2014 | 187 | 2014 |
| Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas GE Lind, SA Danielsen, T Ahlquist, MA Merok, K Andresen, RI Skotheim, ... Molecular cancer 10, 1-15, 2011 | 179 | 2011 |
| Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III … R Dienstmann, G Villacampa, A Sveen, MJ Mason, D Niedzwiecki, ... Annals of oncology 30 (10), 1622-1629, 2019 | 173 | 2019 |
| MiR-9,-31, and-182 deregulation promote proliferation and tumor cell survival in colon cancer L Cekaite, JK Rantala, J Bruun, M Guriby, TH Ågesen, SA Danielsen, ... Neoplasia 14 (9), 868-IN21, 2012 | 167 | 2012 |
| Anastomotic leak following mesorectal excision for rectal cancer: true incidence and diagnostic challenges A Nesbakken, K Nygaard, OC Lunde, J Blücher, Ø Gjertsen, R Dullerud Colorectal Disease 7 (6), 576-581, 2005 | 156 | 2005 |
